BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31319547)

  • 1. Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study.
    Bhattarai S; Klimov S; Mittal K; Krishnamurti U; Li XB; Oprea-Ilies G; Wetherilt CS; Riaz A; Aleskandarany MA; Green AR; Ellis IO; Cantuaria G; Gupta M; Manne U; Agboola J; Baskovich B; Janssen EAM; Callagy G; Walsh EM; Mehta A; Dogra A; Shet T; Gajaria P; Traina T; Nggada HA; Omonisi A; Ahmed SA; Rakha EA; Rida P; Aneja R
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31319547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer.
    Maeda T; Nakanishi Y; Hirotani Y; Fuchinoue F; Enomoto K; Sakurai K; Amano S; Nemoto N
    Med Mol Morphol; 2016 Mar; 49(1):11-21. PubMed ID: 26009308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological features and androgen receptor expression in triple negative breast cancer at Lagos, Nigeria.
    Haruna M; Daramola AO; Awolola NA; Badr NM; Banjo AAF; Shaaban A
    Ecancermedicalscience; 2022; 16():1452. PubMed ID: 36405944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-Expression of Androgen Receptor and Cathepsin D Defines a Triple-Negative Breast Cancer Subgroup with Poorer Overall Survival.
    Mansouri H; Alcaraz LB; Mollevi C; Mallavialle A; Jacot W; Boissière-Michot F; Simony-Lafontaine J; Laurent-Matha V; Roger P; Liaudet-Coopman E; Guiu S
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of androgen receptor in triple negative breast cancer: A meta-analysis.
    Wang C; Pan B; Zhu H; Zhou Y; Mao F; Lin Y; Xu Q; Sun Q
    Oncotarget; 2016 Jul; 7(29):46482-46491. PubMed ID: 27374089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor expression in triple negative breast carcinoma and its association with the clinicopathological parameters.
    Teoh PY; Tan GC; Mahsin H; Wong YP
    Malays J Pathol; 2019 Aug; 41(2):125-132. PubMed ID: 31427547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer.
    Asano Y; Kashiwagi S; Goto W; Tanaka S; Morisaki T; Takashima T; Noda S; Onoda N; Ohsawa M; Hirakawa K; Ohira M
    Cancers (Basel); 2017 Jan; 9(1):. PubMed ID: 28067809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between androgen receptor status and prognosis in triple negative breast cancer.
    Sunar V; T Dogan H; Sarici F; Ates O; Akin S; Baspinar B; Aksoy S; Altundag K
    J BUON; 2018; 23(5):1325-1330. PubMed ID: 30570854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging features of triple-negative breast cancers according to androgen receptor status.
    Candelaria RP; Adrada BE; Wei W; Thompson AM; Santiago L; Lane DL; Huang ML; Arribas EM; Rauch GM; Symmans WF; Gilcrease MZ; Huo L; Lim B; Ueno NT; Moulder SL; Yang WT
    Eur J Radiol; 2019 May; 114():167-174. PubMed ID: 31005169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor expression predicts decreased survival in early stage triple-negative breast cancer.
    Choi JE; Kang SH; Lee SJ; Bae YK
    Ann Surg Oncol; 2015 Jan; 22(1):82-9. PubMed ID: 25145503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?
    Dubrava AL; Kyaw PSP; Newman J; Pringle J; Westhuyzen J; La Hera Fuentes G; Shakespeare TP; Sakalkale R; Aherne NJ
    Breast Cancer (Dove Med Press); 2023; 15():359-371. PubMed ID: 37197610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the androgen receptor in triple-negative breast cancer.
    Rampurwala M; Wisinski KB; O'Regan R
    Clin Adv Hematol Oncol; 2016 Mar; 14(3):186-93. PubMed ID: 27058032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of Androgen Receptor Expression Selects for Basal-Like Phenotype and Is a Predictor of Poor Clinical Outcome in Non-Metastatic Triple Negative Breast Cancer.
    Riaz N; Idress R; Habib S; Lalani EN
    Front Oncol; 2020; 10():1083. PubMed ID: 32850312
    [No Abstract]   [Full Text] [Related]  

  • 14. Claudin 4 expression in triple-negative breast cancer: correlation with androgen receptors and Ki-67 expression.
    Abd-Elazeem MA; Abd-Elazeem MA
    Ann Diagn Pathol; 2015 Feb; 19(1):37-42. PubMed ID: 25456318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer.
    Dagher E; Royer V; Buchet P; Abadie J; Loussouarn D; Campone M; Nguyen F
    BMC Cancer; 2019 Dec; 19(1):1267. PubMed ID: 31888566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Androgen Receptor Promotes Cellular Proliferation by Suppression of G-Protein Coupled Estrogen Receptor Signaling in Triple-Negative Breast Cancer.
    Shen Y; Yang F; Zhang W; Song W; Liu Y; Guan X
    Cell Physiol Biochem; 2017; 43(5):2047-2061. PubMed ID: 29059676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and Prognostic Significance of Androgen Receptors (AR) in Indian Triple-Negative Breast Cancer (TNBC).
    Mishra A; Mishra SK; Sharanappa V; Krishnani N; Kumari N; Agarwal G
    Indian J Surg Oncol; 2024 Jun; 15(2):250-257. PubMed ID: 38741650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor expression is a favorable prognostic factor in triple-negative breast cancers.
    Zuo T; Wilson P; Cicek AF; Harigopal M
    Hum Pathol; 2018 Oct; 80():239-245. PubMed ID: 29902579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor characteristics and outcome by androgen receptor expression in triple-negative breast cancer patients treated with neo-adjuvant chemotherapy.
    Jongen L; Floris G; Wildiers H; Claessens F; Richard F; Laenen A; Desmedt C; Ardui J; Punie K; Smeets A; Berteloot P; Vergote I; Neven P
    Breast Cancer Res Treat; 2019 Aug; 176(3):699-708. PubMed ID: 31106385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of androgen receptors at serine 515 is a potential prognostic marker for triple negative breast cancer.
    Roseweir AK; McCall P; Scott A; Liew B; Lim Z; Mallon EA; Edwards J
    Oncotarget; 2017 Jun; 8(23):37172-37185. PubMed ID: 28415597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.